home / stock / abvc / abvc news

ABVC News and Press, ABVC BioPharma Inc.

Stock Information
Company Name: ABVC BioPharma Inc.
Stock Symbol: ABVC
Market: NASDAQ
Website: abvcpharma.com
Menu
ABVC ABVC Quote ABVC Short ABVC News ABVC Articles ABVC Message Board
Get ABVC Alerts

News, Short Squeeze, Breakout and More Instantly...
ABVC - ABVC BioPharma Reports 2025 Form 10-K

Total Assets Increase 179% to $21.06 Million as Company Strengthens Asset-Backed Licensing Model   SILICON VALLEY, CA - March 3, 2026 ( NEWMEDIAWIRE ) -  ABVC BioPharma, Inc. (NASDAQ: ABVC) today announced the filing of its Annual Report on Form 10-K for the fiscal year ended Dec...
ABVC - ABVC BioPharma Provides Corporate and Structural Update

SILICON VALLEY, CA - February 24, 2026 ( NEWMEDIAWIRE ) -  ABVC BioPharma, Inc.  (NASDAQ: ABVC) (“ ABVC ” or the “ Company ”), a clinical-stage biopharmaceutical company focused on botanical-derived therapeutics and commercial ingredient platforms, today pro...

ABVC - ABVC BioPharma Highlights Safety Profile of Its Plant-Based ADHD Candidate Amid Growing Concerns About Psychiatric Polypharmacy in the United States

SILICON VALLEY, CA - December 2, 2025 ( NEWMEDIAWIRE ) -  ABVC BioPharma, Inc.  (“ ABVC ” or the “ Company ”) (NASDAQ: ABVC) today addressed recent public discussions surrounding attention-deficit/hyperactivity disorder (ADHD) treatment in the United States...

ABVC - ABVC BioPharma Highlights Strengthened Operations at BioKey's 28,176-sq.-ft. Silicon Valley Facility, Featuring U.S.-Based Multi-Product Capabilities Including Functional Foods, and Expansion Outlook Supporting Up to [1,000] Jobs by 2030

SILICON VALLEY, CA - November 26, 2025 ( NEWMEDIAWIRE ) -  ABVC BioPharma, Inc. (“ ABVC ” or the “ Company ”) (NASDAQ: ABVC)  today announced that its wholly owned subsidiary, BioKey (Cayman), Inc. (“ BioKey ”), has strengthened its opera...
ABVC - ABVC Receives US$250,000 From ForSeeCon; Vitargus(R) Total Licensing Fee up to US$33.5 Million; US$816,000 Already Received

SILICON VALLEY, CA - November 21, 2025 ( NEWMEDIAWIRE ) -  ABVC BioPharma, Inc. (“ ABVC ” or the “ Company ”) (NASDAQ: ABVC) announced today that ForSeeCon Eye Corporation (“ ForSeeCon ”) has made an additional US$250,000 payment...

ABVC - ABVC BioPharma Receives US$240,000 Licensing Payment From OncoX BioPharma; Total Licensing Payments Reach Approximately US$2.53 Million

SILICON VALLEY, CA - November 18, 2025 ( NEWMEDIAWIRE ) - ABVC BioPharma, Inc. (NASDAQ: ABVC) (“ABVC” or the  “Company”) today announced that it has received an additional US$240,000 licensing payment from its partner OncoX BioPharma, Inc. (“OncoXȁ...

ABVC - ABVC BioPharma Reports 230% YoY Licensing Revenue Growth and 181% Asset Expansion in Q3 2025

SILICON VALLEY, CA - November 3, 2025 ( NEWMEDIAWIRE ) -  ABVC BioPharma, Inc. . (NASDAQ: ABVC), a clinical-stage biopharmaceutical company developing therapeutic solutions in central nervous system (CNS), ophthalmology, and oncology/hematology indications, today announced its financial resu...
ABVC - ABVC BioPharma Receives Additional US$100,000 Licensing Payment from OncoX BioPharma, Bringing Total Payments to US$695,950

OncoX’s “Technology × Performance × Asset” Business Model Drives ABVC’s Licensing Portfolio Revaluation SILICON VALLEY, CA - October 31, 2025 ( NEWMEDIAWIRE ) -  ABVC BioPharma, Inc. (NASDAQ: ABVC)  today announced that its oncology partner&#x...

ABVC - ABVC BioPharma Highlighted by U.S. Financial Media as One of the Best Biotech Investments; Q3 Licensing Revenue Reaches $1.27 Million, With Clear Clinical Progress Across CNS and Oncology

SILICON VALLEY, CA - October 17, 2025 ( NEWMEDIAWIRE ) -  ABVC BioPharma, Inc. ( NASDAQ: ABVC) (“ABVC” or the “Company”), a clinical-stage biopharmaceutical company developing innovative therapies in oncology, ophthalmology, and central nervous system (CNS) disor...

ABVC - ABVC BioPharma Has Received a Cumulative Total of US$566,000 Under ForSeeCon Licensing Agreement Supporting GMP Facility in Hsinchu for Vitargus(R) Production

SILICON VALLEY, CA - October 8, 2025 ( NEWMEDIAWIRE ) -  ABVC BioPharma, Inc. (NASDAQ: ABVC) (“ABVC” or the “Company”) today announced that it has received a  US$70,000 licensing payment  from its partner,  ForSeeCon Eye Corporation (“ForSee...
Next 10